Document is current
Any future updates will be listed below
-
Authors
Terui, Tadashi
Murakami, Masamoto
Okubo, Yukari
Hayama, Koremasa
Fujita, Hideki https://orcid.org/0000-0001-8657-0618
- License Information
-
More Information
Article History
Received: 7 November 2024
Accepted: 3 March 2025
First Online: 15 March 2025
Declarations
:
: Tadashi Terui has received research funds from Maruho Co., Ltd., and honoraria for a speaker, consultancy, and advisory board member from AbbVie, Amgen Inc., Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Janssen Pharmaceuticals, Inc., Kyowa Kirin Pharma, Inc., Mitsubishi Tanabe Pharma Co., Novartis, Sanofi, Taiho Pharmaceutical Co., Ltd., UCB Japan. Masamoto Murakami has received research funds from AbbVie and honoraria for a speaker, consultancy, and advisory board member from, Amgen Inc., Boehringer Ingelheim, Bristol Myers Squibb, Janssen Pharmaceuticals, Inc, Kyowa Kirin Pharma, Inc., Taiho Pharmaceutical Co., Ltd., UCB Japan. Yukari Okubo has received research funds from AbbVie, Eisai, Torii Pharmaceutical Co., Ltd., Maruho Co., Ltd., Shiseido, Sun Pharma. Honoraria for a speaker, consultancy, and advisory board member from AbbVie, Amgen Inc., Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Janssen Pharmaceuticals, Inc., Kyowa Kirin Pharma, Inc., LEO Pharma, Maruho Co. Ltd., Novartis Pharma, Pfizer, Sanofi, Sun Pharma, Taiho Pharmaceutical Co., Ltd., UCB Japan Pharma, and honoraria for a speaker from Eisai, Jimro, Mitsubishi Tanabe Pharma Co., Torii Pharmaceutical Co., Ltd. Koremasa Hayama has received research funds and honoraria for a speaker from Maruho Co. Ltd, Taiho Pharmaceutical Co., Ltd., and Torii Pharmaceutical Co., Ltd., and honoraria for a speaker, consultancy, and advisory from AbbVie, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc, Novartis, Sanofi, UCB Japan, and honoraria for a speaker from Daiichi Sankyo Co. Ltd, Eli Lilly, Kyowa Kirin Pharma, Inc., Mitsubishi Tanabe Pharma Co., Hideki Fujita has received research grant or honoraria for speaker and/or consultancy from AbbVie, Amgen, Boehringer-Ingelheim, Bristol Myers Squibb, Daiichi-Sanyo, Eisai, Eli Lilly, Janssen, JMEC, Kaken, Kyowa Kirin, LEO, Maruho, Mitsubishi Tanabe, Nihon Pharma, Novartis, Otsuka, Sanofi, Sun Pharma, Taiho, Torii, Towa, UCB, and Ushio.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
